This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
5i38
From Proteopedia
(Difference between revisions)
| (One intermediate revision not shown.) | |||
| Line 1: | Line 1: | ||
==Crystal Structure of tyrosinase from Bacillus megaterium with inhibitor kojic acid in the active site== | ==Crystal Structure of tyrosinase from Bacillus megaterium with inhibitor kojic acid in the active site== | ||
| - | <StructureSection load='5i38' size='340' side='right' caption='[[5i38]], [[Resolution|resolution]] 2.60Å' scene=''> | + | <StructureSection load='5i38' size='340' side='right'caption='[[5i38]], [[Resolution|resolution]] 2.60Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5i38]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5I38 OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[5i38]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Priestia_megaterium Priestia megaterium]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5I38 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5I38 FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CU:COPPER+(II)+ION'>CU</scene>, <scene name='pdbligand=KOJ:5-HYDROXY-2-(HYDROXYMETHYL)-4H-PYRAN-4-ONE'>KOJ</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.6Å</td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CU:COPPER+(II)+ION'>CU</scene>, <scene name='pdbligand=KOJ:5-HYDROXY-2-(HYDROXYMETHYL)-4H-PYRAN-4-ONE'>KOJ</scene></td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5i38 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5i38 OCA], [https://pdbe.org/5i38 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5i38 RCSB], [https://www.ebi.ac.uk/pdbsum/5i38 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5i38 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/B2ZB02_PRIMG B2ZB02_PRIMG] | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 16: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 5i38" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5i38" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Tyrosinase 3D structures|Tyrosinase 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: | + | [[Category: Priestia megaterium]] |
| - | [[Category: | + | [[Category: Adir N]] |
| - | [[Category: | + | [[Category: Deri B]] |
| - | [[Category: | + | [[Category: Fishman A]] |
| - | [[Category: | + | [[Category: Goldfeder M]] |
| - | [[Category: | + | [[Category: Kanteev M]] |
Current revision
Crystal Structure of tyrosinase from Bacillus megaterium with inhibitor kojic acid in the active site
| |||||||||||
